Researchers Developed Genetic Test for Keratoconus
A new polygenic risk score offers an accurate way to detect the eye condition across diverse patient populations.
Updated on Oct. 3, 2026 in Biotech
Live Poll
Would you want regular genetic testing if it meant needing to see a specialist more often?
Researchers have developed a polygenic risk score that successfully distinguishes between patients with keratoconus and healthy individuals. The model demonstrated significant accuracy when tested on a multiethnic group of participants.
Why it matters
This development aims to provide a more inclusive detection method that functions across diverse cohorts to help clinicians manage patient care. Such tools are intended to assist in timing early clinical interventions for those at risk.
The study utilized a cohort of 90 participants, including 40 patients with keratoconus or transplant history, 25 healthy controls, and 25 patients with recurrent keratoconus. The cohort was 35 percent Black, 51 percent white, 5 percent Asian, and 9 percent other ethnicities.
The players
University Hospitals Eye Institute
This Cleveland-based facility serves as a major center for clinical eye research and patient care.
Million Veteran Program
This national research program manages a massive database of genetic and health information used to advance medical discovery.
The details
The research team at the University Hospitals Eye Institute created the score by combining previously reported genetic associations with data from the Million Veteran Program. This methodology improves upon previous detection models by ensuring broader applicability across different ethnic groups.
Timeline
October 2026: Researchers presented the study data at the Academy 2026 conference.
The Tech Race
This genetic diagnostic tool reflects a wider trend toward moving beyond legacy, single-ancestry models to improve health equity. It follows the precedent established by the Hardcastle study while optimizing accuracy for broader multiethnic populations.
This research could lead to improved clinical diagnostic tools that allow eye specialists in Cleveland and beyond to identify risk earlier. Patients may benefit from more personalized management plans and better-timed medical interventions based on their specific genetic profiles.
The takeaway
Advancements in polygenic risk scoring are essential for ensuring diagnostic tools work effectively for all patients regardless of background. Implementing these tests in clinical practice could provide doctors with a more objective way to monitor corneal health over time.
Further reading
Learn more about the latest innovations in Biotech to see how genetic testing is evolving.
Source note: This article includes information reported by Healio.
Live Poll
Would you want regular genetic testing if it meant needing to see a specialist more often?
